Previously submitted to: JMIR Cancer (no longer under consideration since Mar 27, 2023)
Date Submitted: Dec 24, 2021
Open Peer Review Period: Dec 24, 2021 - Feb 18, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer-Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Designing a Healthcare Technology Platform Framework for Purpose-Driven Oncology in a Developing Country Healthcare Context
ABSTRACT
The rising cases of cancer in India and the unequal care has given rise to large out-of-pocket expenses and late stage of detection of cares, leading to higher mortality rates in many states across rural India. Investing in digital health in resource-constrained countries could provide cancer diagnosis and treatment at affordable costs, improve availability and health outcomes for the citizens. This paper introduces the framework and features of a healthcare technology platform for a developing country to democratise oncology health care services. The framework relies on participatory systems, patient first algorithms and digital health exchange mechanisms. The proposed platform is built on three key pillars of Technology, Managed Healthcare and Advisory, each with a unique value proposition, yet will be complementary, and tries to address specific requirements across the healthcare delivery value chain, thereby, providing a comprehensive solution to the overall problem of the ecosystem. We discuss the application of the framework and usage of curated data and robust workflow and rules engine to enable seamless flow of information across all levels, while bringing close home care to people. We propose that a technology platform, build on a connected care ecosystem, could improve cancer care outcomes in a developing country healthcare context.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.